AU1979799A - Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers - Google Patents
Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockersInfo
- Publication number
- AU1979799A AU1979799A AU19797/99A AU1979799A AU1979799A AU 1979799 A AU1979799 A AU 1979799A AU 19797/99 A AU19797/99 A AU 19797/99A AU 1979799 A AU1979799 A AU 1979799A AU 1979799 A AU1979799 A AU 1979799A
- Authority
- AU
- Australia
- Prior art keywords
- uro
- derivatives useful
- selective alpha
- adrenoceptor blockers
- arylpiperazine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
- C07D207/408—Radicals containing only hydrogen and carbon atoms attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/120,265 US6083950A (en) | 1997-11-13 | 1998-07-21 | 1-(4-arylpiperazin-1-yl)-ω-[n-(α,ω-dicarboximido)]-alka nes useful as uro-selective α1-adrenoceptor blockers |
| US09120265 | 1998-07-21 | ||
| PCT/IB1999/000140 WO2000005206A1 (en) | 1998-07-21 | 1999-01-26 | Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1979799A true AU1979799A (en) | 2000-02-14 |
Family
ID=22389214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU19797/99A Abandoned AU1979799A (en) | 1998-07-21 | 1999-01-26 | Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers |
Country Status (10)
| Country | Link |
|---|---|
| CN (1) | CN1168714C (en) |
| AR (1) | AR019438A1 (en) |
| AU (1) | AU1979799A (en) |
| CO (1) | CO5241280A1 (en) |
| CZ (1) | CZ2001235A3 (en) |
| ID (1) | ID28198A (en) |
| MY (1) | MY120255A (en) |
| RU (1) | RU2221794C2 (en) |
| WO (1) | WO2000005206A1 (en) |
| ZA (1) | ZA200100440B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050228180A1 (en) * | 2002-04-08 | 2005-10-13 | Mohammad Salman | Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers |
| US7053355B2 (en) | 2003-03-18 | 2006-05-30 | Brion Technologies, Inc. | System and method for lithography process monitoring and control |
| WO2005037281A1 (en) * | 2003-10-15 | 2005-04-28 | Ranbaxy Laboratories Limited | 1-alkylpiperazinyl-pyrrolidin-2, 5-dione derivatives as adrenergic receptor antagonist |
| WO2005113498A1 (en) * | 2004-05-19 | 2005-12-01 | Ranbaxy Laboratories Limited | Adrenergic receptor antagonists |
| WO2005118591A1 (en) * | 2004-05-31 | 2005-12-15 | Ranbaxy Laboratories Limited | Condensed piperidine compounds acting as adrenergic receptor antagonists useful in the treatment of prostatic hyperplasia and lower urinary symptoms |
| WO2006018815A1 (en) * | 2004-08-16 | 2006-02-23 | Ranbaxy Laboratories Limited | Piperazine derivatives as adrenergic receptor antagonists |
| WO2006051374A2 (en) * | 2004-11-11 | 2006-05-18 | Ranbaxy Laboratories Limited | Arylpiperazines useful as adrenergic receptor antagonists |
| CN103864761B (en) * | 2014-03-12 | 2016-01-20 | 天津药物研究院有限公司 | A kind of piperazine derivative containing pyridine and its production and use |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE788280A (en) * | 1971-09-04 | 1973-02-28 | Pfizer | NEWS 1- (3-TRIFLUORO-METHYL-PHENYL) -4 - ((CYCLIC AMIDO) - ALKYL) PIPERAZINES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM |
| DE2727469A1 (en) * | 1977-06-18 | 1978-12-21 | Hoechst Ag | NEW HEXAHYDROPYRIMIDINE, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
| JPS57197265A (en) * | 1981-05-29 | 1982-12-03 | Eisai Co Ltd | Carboxylic acid imide derivative, its preparation and medicament containing the same |
| US4452798A (en) * | 1982-06-22 | 1984-06-05 | Warner-Lambert Company | 1-Substituted phenyl-4-alkyl hydantoin piperazine compounds as antihypertensive agents |
| US4675403A (en) * | 1985-10-16 | 1987-06-23 | American Home Products Corporation | 3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity |
| ES2094690B1 (en) * | 1994-11-22 | 1997-08-01 | Univ Madrid Complutense | NEW DERIVATIVES OF IMIDA-PIPERAZINES. |
| ATE201016T1 (en) * | 1995-06-09 | 2001-05-15 | Hoffmann La Roche | PYRIMIDINDIONE, PYRIMIDINDRION, TRIAZINDIONE DERIVATIVES AS ALPHA-1 ADRENERGIC RECEPTOR ANTAGONISTS |
-
1999
- 1999-01-26 AU AU19797/99A patent/AU1979799A/en not_active Abandoned
- 1999-01-26 WO PCT/IB1999/000140 patent/WO2000005206A1/en active Application Filing
- 1999-07-16 CZ CZ2001235A patent/CZ2001235A3/en unknown
- 1999-07-16 ID IDW20010184A patent/ID28198A/en unknown
- 1999-07-16 RU RU2001104892/04A patent/RU2221794C2/en not_active IP Right Cessation
- 1999-07-16 CN CNB998108421A patent/CN1168714C/en not_active Expired - Fee Related
- 1999-07-20 MY MYPI99003045A patent/MY120255A/en unknown
- 1999-07-21 CO CO99045842A patent/CO5241280A1/en not_active Application Discontinuation
- 1999-07-21 AR ARP990103573A patent/AR019438A1/en not_active Application Discontinuation
-
2001
- 2001-01-16 ZA ZA200100440A patent/ZA200100440B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO5241280A1 (en) | 2003-01-31 |
| CZ2001235A3 (en) | 2001-08-15 |
| WO2000005206A8 (en) | 2000-03-16 |
| RU2221794C2 (en) | 2004-01-20 |
| MY120255A (en) | 2005-09-30 |
| ID28198A (en) | 2001-05-10 |
| CN1318052A (en) | 2001-10-17 |
| CN1168714C (en) | 2004-09-29 |
| WO2000005206A1 (en) | 2000-02-03 |
| ZA200100440B (en) | 2002-10-04 |
| AR019438A1 (en) | 2002-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5196399A (en) | Novel sulfonyl derivatives | |
| AU2623899A (en) | Novel thiobenzamides | |
| AU4260199A (en) | Novel compounds | |
| AU2616199A (en) | Novel bicyclene-substituted oxazolidinones | |
| AU2014800A (en) | Novel compounds | |
| AU5980899A (en) | Novel compounds | |
| AU2350199A (en) | Novel aminoorganofunctionalsiloxanes | |
| AU1379900A (en) | Novel substituted phenyloxazolidone derivatives | |
| AU5444499A (en) | Benzoxazine derivatives | |
| AU1979799A (en) | Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers | |
| AU4814699A (en) | Novel compounds | |
| AU4037699A (en) | Novel aryl-hydro naphthalenal kanamines | |
| AU1747799A (en) | Solid laser not requiring alignment | |
| AU6228299A (en) | 2-substituted-d-homooxasteroid derivatives | |
| AU5516599A (en) | Substituted 3-aryl-pyrazoles | |
| AU2187799A (en) | Novel taxaneterpine compounds | |
| AU2724799A (en) | Novel endo-xylogalacturonase | |
| AU2640999A (en) | 1-azaindolizine derivatives | |
| AU6994600A (en) | Substituted benzoxazoles | |
| PL345562A1 (en) | Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers | |
| AU4141099A (en) | Pyrazolyldioxothiochromanoyl derivatives | |
| AU5239899A (en) | Amidophosphate derivatives | |
| AU2894099A (en) | Phenanthrofuran derivatives | |
| AU4507899A (en) | Substituted n-aryl-o-alkyl-carbamates | |
| AU1785599A (en) | Novel pyrimidine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |